Larvol Delta - Asher-Bio-Announces-Clinical-Supply-Agreement-to-Enable-Evaluation-of-Etakafusp-Alfa-AB248-in-Combination-with-Rilvegostomig-in-a-Global-Phase-1b2-Study-in-NonSmall-Cell-Lung-Cancer-NSCLC

etakafusp alfa (AB248) - Asher Biotherap

https://www.businesswire.com/news/home/20250107837910/en/Asher-Bio-Announces-Clinical-Supply-Agreement-to-Enable-Evaluation-of-Etakafusp-Alfa-AB248-in-Combination-with-Rilvegostomig-in-a-Global-Phase-1b2-Study-in-Non-Small-Cell-Lung-Cancer-NSCLC

Jan 7, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next